In line with our commitment to transparency as one of ROVI’s strategic pillars, the mangement team will hold a virtual meeting with analysts and investors tomorrow, September 30 at 15:00 CET (Continental European Time), to discuss the acquisition of a drug product manufacturing site in Phoenix, Arizona (USA).
To join the meeting, please click on this link: ROVI Corporate Communication
Tuesday, 30 Sep 2025